Literature DB >> 2730254

Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease.

E H Cheng1, P Bermanski, M Silversmith, P Valenstein, H Kawanishi.   

Abstract

The relationship between the presence of Campylobacter pylori and esophagitis was studied in patients undergoing paired biopsies of distal esophagus and gastric antrum during esophagogastroduodenoscopy. Biopsy specimens were examined for urease activity and for the presence of C pylori by culture and by histologic examination of hematoxylin-eosin- and Warthin-Starry-stained sections. Sixty-two patients were entered into the study. All esophageal biopsy specimens, regardless of histologic findings, were negative for the presence of C pylori by urease test, culture, and histologic examination. Of 35 patients with normal esophageal biopsy specimens, 11 (31%) had antral specimens that were positive for C pylori, while 11 (41%) of the 27 patients with esophagitis had antral specimens that were positive for the organism. Campylobacter pylori was detected in 14 (70%) of 20 patients with chronic gastritis, in 8 (67%) of 12 patients with endoscopically documented duodenal ulcers and erosions, but in only 3 (33%) of 9 patients with endoscopically defined duodenitis. We conclude that histologic esophagitis is not associated with increased prevalence of either gastric or esophageal C pylori. The well-described association of chronic gastritis and duodenal ulcers with C pylori was present in our study population.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730254

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  12 in total

Review 1.  Gastro-oesophageal reflux disease and Helicobacter pylori: an intricate relation.

Authors:  D McNamara; C O'Morain
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

Review 2.  Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.

Authors:  Anan Raghunath; A Pali S Hungin; David Wooff; Susan Childs
Journal:  BMJ       Date:  2003-04-05

3.  Corpus gastritis is protective against reflux oesophagitis.

Authors:  H B El-Serag; A Sonnenberg; M M Jamal; J M Inadomi; L A Crooks; R M Feddersen
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

4.  Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects.

Authors:  Y Yamaji; T Mitsushima; H Ikuma; M Okamoto; H Yoshida; T Kawabe; Y Shiratori; K Saito; K Yokouchi; M Omata
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

5.  H. pylori infection and reflux oesophagitis: a case-control study.

Authors:  Rahim Masjedizadeh; Eskandar Hajiani; Koorosh Moezardalan; Saeed Samie; Mohammad-Javad Ehsani-Ardakani; Ali Daneshmand; Mohammad-Reza Zali
Journal:  World J Gastroenterol       Date:  2006-09-21       Impact factor: 5.742

6.  No protective role of Helicobacter pylori in the pathogenesis of reflux esophagitis in patients with duodenal or benign gastric ulcer in Korea.

Authors:  N Kim; S H Lim; K H Lee
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

Review 7.  Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview.

Authors:  S J Veldhuyzen van Zanten; P M Sherman
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

8.  Possible role of Helicobacter pylori serology in reducing endoscopy workload.

Authors:  T C Tham; N McLaughlin; D F Hughes; M Ferguson; J J Crosbie; M Madden; S Namnyak; F A O'Connor
Journal:  Postgrad Med J       Date:  1994-11       Impact factor: 2.401

9.  Increased reflux symptoms after calcium carbonate supplementation and successful anti-Helicobacter pylori treatment.

Authors:  Lori A Fischbach; Pelayo Correa; Mark Feldman; Elizabeth Fontham; Elisa Priest; Karen J Goodman; Rajeev Jain
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

Review 10.  Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease?

Authors:  J M Lee; C A O'Morain
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.